- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.69B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.7B sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 1.74B sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2025 | 1.73B sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $350.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $257.1M |
| Capex | Q1 2026 · Mar 31, 2026 | $40.77M |
| Capex | Q1 2026 · Mar 31, 2025 | $37.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $326.78M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $151.61M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.49B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.49B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $46.99M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $46.97M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.06B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.03B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $911.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.08B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.28B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.31B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.21B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.29B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.42B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.4B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.28B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.58B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.5B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.68B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $220.69M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $235.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $478.3M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $424.17M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$88.95M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$139.59M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$74.45M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$193.85M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $665.24M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $639.58M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.53B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.36B |